These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8062954)

  • 41. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method.
    Jinno M; Katsumata Y; Hoshiai T; Nakamura Y; Matsumoto K; Yoshimura Y
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3603-11. PubMed ID: 9360514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two cases of ovarian tumours in women who had undergone multiple ovarian stimulation attempts.
    Grimbizis G; Tarlatzis BC; Bontis J; Miliaras D; Lagos S; Pournaropoulos F; Mantalenakis S
    Hum Reprod; 1995 Mar; 10(3):520-3. PubMed ID: 7782425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
    Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
    Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
    Xi W; Liu S; Mao H; Yang Y; Xue X; Lu X
    Drug Des Devel Ther; 2015; 9():6001-8. PubMed ID: 26648691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early cessation of triptorelin in in vitro fertilization: a double-blind, randomized study.
    Simons AH; Roelofs HJ; Schmoutziguer AP; Roozenburg BJ; van't Hof-van den Brink EP; Schoonderwoerd SA
    Fertil Steril; 2005 Apr; 83(4):889-96. PubMed ID: 15820796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing their first treatment cycle of IVF or ICSI.
    Bjercke S; Tanbo T; Abyholm T; Omland A; Opøien HK; Fedorcsak P
    Acta Obstet Gynecol Scand; 2010 Aug; 89(8):1053-60. PubMed ID: 20602599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of ovarian cysts on the results of in vitro fertilization.
    Parinaud J; Cohen K; Oustry P; Perineau M; Monroziès X; Rème JM
    Fertil Steril; 1992 Dec; 58(6):1174-7. PubMed ID: 1459269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program.
    Acharya U; Small J; Randall J; Hamilton M; Templeton A
    Fertil Steril; 1992 Apr; 57(4):815-8. PubMed ID: 1555693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian stimulation of IVF patients: effects of the reversible hypogonadotrophic state induced by GnRH agonist.
    Crosignani PG; Ragni G; Lombroso GC; Scarduelli C; De Lauretis L; Caccamo A; Dalprà L; Cavioni V; Cristiani C; Wyssling H
    Hum Reprod; 1988 Oct; 3 Suppl 2():39-41. PubMed ID: 3147991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Factors affecting the results of in vitro fertilization--IV. Importance of the stimulation protocols combining GnRH analogs and HMG in women with unsuccessful stimulation with combinations of clomiphene citrate-HMG].
    Mardesic T; Müller P; Zetová L; Miková M; Stroufová A
    Ceska Gynekol; 1995 Apr; 60(2):74-8. PubMed ID: 7767590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is long-protocol gonadotropin releasing hormone agonist administration superior to the short protocol in ovarian stimulation for in vitro fertilization?
    Tasdemir M; Tasdemir I; Kodama H; Higuchi M
    Int J Fertil Menopausal Stud; 1995; 40(1):25-8. PubMed ID: 7749431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.
    Rutherford AJ; Subak-Sharpe RJ; Dawson KJ; Margara RA; Franks S; Winston RM
    Br Med J (Clin Res Ed); 1988 Jun; 296(6639):1765-8. PubMed ID: 3136830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer.
    Goldman JA; Dicker D; Feldberg D; Ashkenazi J; Voliowich I
    Hum Reprod; 1994 Feb; 9(2):226-8. PubMed ID: 8027276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial.
    Fedele L; Parazzini F; Radici E; Bocciolone L; Bianchi S; Bianchi C; Candiani GB
    Am J Obstet Gynecol; 1992 May; 166(5):1345-50. PubMed ID: 1595789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program.
    Kondaveeti-Gordon U; Harrison RF; Barry-Kinsella C; Gordon AC; Drudy L; Cottell E
    Fertil Steril; 1996 Oct; 66(4):582-6. PubMed ID: 8816620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response.
    Ibrahim ZH; Matson PL; Buck P; Lieberman BA
    Fertil Steril; 1991 Jan; 55(1):202-4. PubMed ID: 1898890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ["Long protocol" for ovarian stimulation using D-Trp6 LHRH (Triptorelin Depot) and menopausal gonadotropin in the IVF-ET program].
    Kulikowski M; Wołczyński S; Grochowski D; Kuczyński W; Sola E; Szamatowicz J; Syrewicz M; Domitrz J; Szamatowicz M
    Ginekol Pol; 1996 May; 67(5):243-7. PubMed ID: 8925995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Combined GnRH agonist/hMG therapy and ovarian overstimulation syndrome].
    Lindner C; Braendle W; Lichtenberg V; Bettendorf G
    Arch Gynecol Obstet; 1989; 245(1-4):860-1. PubMed ID: 2529827
    [No Abstract]   [Full Text] [Related]  

  • 59. Selection of ovarian stimulation protocol is related to IVF treatment outcome in women 35 years of age and older.
    Csemiczky G; Hagenfeldt K; Wramsby H
    J Assist Reprod Genet; 1994 Oct; 11(9):474-7. PubMed ID: 7633169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol.
    Diamond MP; Maxson WS; Vaughn WK; Osteen KG; Wentz AC
    J In Vitro Fert Embryo Transf; 1986 Apr; 3(2):106-9. PubMed ID: 3084690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.